Detailed information for compound 1575243

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 404.485 | Formula: C22H20N4O2S
  • H donors: 2 H acceptors: 1 LogP: 4.16 Rotable bonds: 6
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1ccc(cc1)NC(=S)Nc1ccc2c(c1)c(=O)n(n2c1ccccc1)C
  • InChi: 1S/C22H20N4O2S/c1-25-21(27)19-14-16(10-13-20(19)26(25)17-6-4-3-5-7-17)24-22(29)23-15-8-11-18(28-2)12-9-15/h3-14H,1-2H3,(H2,23,24,29)
  • InChiKey: OCJOJUYRECVREF-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Echinococcus granulosus geminin 0.0179 0.5437 0.5437
Schistosoma mansoni hypothetical protein 0.0179 0.5437 0.5437
Loa Loa (eye worm) MH2 domain-containing protein 0.0144 0.4223 1
Echinococcus multilocularis high voltage activated calcium channel beta 0.031 1 1
Trypanosoma brucei guanylate kinase, putative 0.0023 0 0.5
Onchocerca volvulus 0.0023 0 0.5
Plasmodium falciparum guanylate kinase 0.0023 0 0.5
Trichomonas vaginalis discs large, putative 0.0023 0 0.5
Plasmodium vivax guanylate kinase, putative 0.0023 0 0.5
Brugia malayi MH2 domain containing protein 0.0144 0.4223 1
Mycobacterium leprae Probable guanylate kinase Gmk (GMP kinase). 0.0023 0 0.5
Entamoeba histolytica guanylate kinase, putative 0.0023 0 0.5
Mycobacterium tuberculosis Probable guanylate kinase Gmk 0.0023 0 0.5
Trichomonas vaginalis calcium/calmodulin-dependent serine protein kinase membrane-associated guanylate kinase, putative 0.0023 0 0.5
Trypanosoma cruzi guanylate kinase, putative 0.0023 0 0.5
Loa Loa (eye worm) transcription factor SMAD2 0.0144 0.4223 1
Trichomonas vaginalis sap-102, putative 0.0023 0 0.5
Echinococcus multilocularis geminin 0.0179 0.5437 0.5437
Giardia lamblia Guanylate kinase 0.0023 0 0.5
Leishmania major guanylate kinase, putative 0.0023 0 0.5
Trichomonas vaginalis guanylate kinase, putative 0.0023 0 0.5
Mycobacterium ulcerans guanylate kinase 0.0023 0 0.5
Wolbachia endosymbiont of Brugia malayi guanylate kinase 0.0023 0 0.5
Chlamydia trachomatis guanylate kinase 0.0023 0 0.5
Schistosoma mansoni high voltage-activated calcium channel beta subunit 1 0.031 1 1
Trypanosoma brucei guanylate kinase, putative 0.0023 0 0.5
Leishmania major guanylate kinase-like protein 0.0023 0 0.5
Toxoplasma gondii guanylate kinase family protein 0.0023 0 0.5
Schistosoma mansoni hypothetical protein 0.0179 0.5437 0.5437
Trypanosoma cruzi guanylate kinase, putative 0.0023 0 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 11.2202 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) 29.9349 uM PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.